If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
559.00    3.00 (0.54%)
Bid:
556.50
Ask:
557.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Apr 2018 16:31

Tate & Lyle PLC

Notification of transactions by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that it was informed yesterday that transactions occurred by Persons Discharging Managerial Responsibilities (‘PDMR’) in respect of their interests in ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the 2016 Conditional Share Award programme (‘CSA’).

No consideration was paid for the acquisition of these Shares. Awards made under the CSA were subject to certain Company-based financial performance criteria satisfied over a performance period which ran from 1 April 2016 to 31 March 2017. The Awards were further subject to a 12-month deferral period and continued employment to 31 March 2018.

Following the withholding of Shares to satisfy certain tax obligations arising on the exercise of nil-cost options or the release of Shares, the PDMR’s interests in Shares changed as detailed in the table below:

PDMR   Date of Transaction   No. of Shares acquired under the CSA
Rowan Adams 4 April 2018 25,144
Joan Braca 3 April 2018 37,814
Jim Stutelberg 3 April 2018 25,170

For tax purposes, the market value of the Shares, being the average of the two close prices on the date of the transaction, was 542.4 pence per Share on 4 April 2018 and 537.6 pence per Share on 3 April 2018.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’Grady Company Secretary 5 April 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive Vice President, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the exercise of nil-cost options over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,144

d) Aggregated information

 

Aggregated volume Price

25,144 Nil

 

e) Date of the transaction 2017-04-04
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Joan Braca
2. Reason for the notification
a) Position / status PDMR – President, Speciality Food Ingredients
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 37,814

d) Aggregated information

 

Aggregated volume Price

37,814 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

    Details of PDMR / person closely associated with them (“PCA”)
a) Name   Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b) Nature of the transaction Acquisition of shares following the release of nil-cost conditional awards over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Nil

 

 

Volume(s) 25,170

d) Aggregated information

 

Aggregated volume Price

25,170 Nil

e) Date of the transaction 2017-04-03
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20180405005843/en/

Copyright Business Wire 2018

Date   Source Headline
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company
29th Apr 20253:30 pmRNSHolding(s) in Company
28th Apr 20255:15 pmRNSHolding(s) in Company
24th Apr 202512:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSIntegration update and pre-close statement
27th Mar 20257:00 amRNSDirectorate Change
14th Mar 202510:05 amRNSDirectorate declaration
11th Mar 20253:00 pmRNSHolding(s) in Company
5th Mar 202511:30 amRNSDirector/PDMR Shareholding
28th Feb 20254:30 pmRNSHolding(s) in Company
28th Feb 202510:15 amRNSDirector/PDMR Shareholding
27th Feb 20257:00 amRNSAdditional Listing
20th Feb 20251:42 pmRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTrading Statement
4th Feb 20257:05 amRNSDirector Declaration
3rd Feb 20253:30 pmRNSTotal Voting Rights
23rd Jan 20255:30 pmRNSIssue of Debt
9th Jan 20255:54 pmRNSCompletion of Share Buyback Programme
9th Jan 20255:45 pmRNSTransaction in Own Shares
8th Jan 20255:17 pmRNSTransaction in Own Shares
8th Jan 20252:02 pmRNSDirector/PDMR Shareholding
7th Jan 20255:31 pmRNSTransaction in Own Shares
6th Jan 20256:10 pmRNSTransaction in Own Shares
6th Jan 20252:00 pmRNSDirectorate Change
3rd Jan 20255:28 pmRNSTransaction in Own Shares
2nd Jan 20255:20 pmRNSTransaction in Own Shares
2nd Jan 20252:10 pmRNSBlock listing Interim Review
2nd Jan 20252:00 pmRNSTotal Voting Rights
30th Dec 20245:36 pmRNSTransaction in Own Shares
27th Dec 20245:15 pmRNSTransaction in Own Shares
23rd Dec 20245:26 pmRNSTransaction in Own Shares
20th Dec 20245:31 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.